Akio Yamasaki

Summary

Affiliation: Kyushu University
Country: Japan

Publications

  1. ncbi Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh
    Akio Yamasaki
    Department of Cancer Therapy and Research, Kyushu University, Maidashi, Higashi ku, Fukuoka, Japan
    Cancer Immunol Immunother 59:675-86. 2010
  2. ncbi Surface-bound TGF-beta1 on effusion-derived exosomes participates in maintenance of number and suppressive function of regulatory T-cells in malignant effusions
    Junji Wada
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    Anticancer Res 30:3747-57. 2010
  3. ncbi The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer
    Chizu Kameda
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Higashi ku, Fukuoka 812 8582, Japan
    Anticancer Res 29:871-9. 2009
  4. ncbi A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model
    Akio Yamasaki
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Higashi ku, Fukuoka 812 8582, Japan
    Anticancer Res 29:843-50. 2009
  5. ncbi The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions
    Junji Wada
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Higashi ku, Fukuoka 812 8582, Japan
    Anticancer Res 29:881-8. 2009
  6. ncbi Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway
    Mio Ikebe
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    J Surg Oncol 100:725-31. 2009
  7. ncbi VEGFR2 is selectively expressed by FOXP3high CD4+ Treg
    Hiroyuki Suzuki
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    Eur J Immunol 40:197-203. 2010
  8. ncbi Dual blockade of phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancer
    Rui Xu
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Japan
    Cancer Lett 306:151-60. 2011
  9. ncbi Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer
    Hiroyuki Suzuki
    Department of Cancer Therapy and Research, Kyushu University, Maidashi, Higashi ku, Fukuoka, Japan
    Cancer Immunol Immunother 59:653-61. 2010
  10. ncbi Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancer
    Akio Yamasaki
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, 3 1 1 Maidashi, Higashi ku, Fukuoka 812 8582, Japan
    Anticancer Res 31:2419-24. 2011

Collaborators

Detail Information

Publications11

  1. ncbi Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh
    Akio Yamasaki
    Department of Cancer Therapy and Research, Kyushu University, Maidashi, Higashi ku, Fukuoka, Japan
    Cancer Immunol Immunother 59:675-86. 2010
    ....
  2. ncbi Surface-bound TGF-beta1 on effusion-derived exosomes participates in maintenance of number and suppressive function of regulatory T-cells in malignant effusions
    Junji Wada
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    Anticancer Res 30:3747-57. 2010
    ..This study analysed the contribution of malignant-effusion derived exosomes (Eff-Ex) to the number and function of regulatory T-cells (Treg) in malignant effusions...
  3. ncbi The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer
    Chizu Kameda
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Higashi ku, Fukuoka 812 8582, Japan
    Anticancer Res 29:871-9. 2009
    ....
  4. ncbi A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model
    Akio Yamasaki
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Higashi ku, Fukuoka 812 8582, Japan
    Anticancer Res 29:843-50. 2009
    ..Based on these observations, in the present study the possibility that PSK could enhance TXT-mediated tumor suppression was examined in vivo and in vitro...
  5. ncbi The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions
    Junji Wada
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Higashi ku, Fukuoka 812 8582, Japan
    Anticancer Res 29:881-8. 2009
    ..Taken together, the data presented here indicate a contribution of VEGF to induction and/or maintenance of Tregs in patients with cancer...
  6. ncbi Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway
    Mio Ikebe
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    J Surg Oncol 100:725-31. 2009
    ..We have shown that lipopolysaccharide (LPS) promotes NF-kappaB activation in colon cancer cells and pancreatic cancer cells. However, it is unclear why inflammatory stimuli can induce NF-kappaB activation in cancer cells...
  7. ncbi VEGFR2 is selectively expressed by FOXP3high CD4+ Treg
    Hiroyuki Suzuki
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    Eur J Immunol 40:197-203. 2010
    ..Such VEGFR2+ Treg exist in several tissues including PBMC and malignant effusion-derived lymphocytes. In conclusion, VEGFR2 may be a novel target for controlling Treg with highly suppressive function...
  8. ncbi Dual blockade of phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancer
    Rui Xu
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Japan
    Cancer Lett 306:151-60. 2011
    ..In conclusion, PI3K is involved in low susceptibility of colorectal cancer to paclitaxel and dual PI3K/MAPK targeting agents may evolve a new paclitaxel-based chemotherapy for colorectal cancer...
  9. ncbi Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer
    Hiroyuki Suzuki
    Department of Cancer Therapy and Research, Kyushu University, Maidashi, Higashi ku, Fukuoka, Japan
    Cancer Immunol Immunother 59:653-61. 2010
    ..Importantly, itCD8(+) T/itFOXP3(+) cell ratio may be an independent prognostic factor. And, tumor-producing TGF-beta may contribute to the increased number of itFOXP3(+) cells...
  10. ncbi Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancer
    Akio Yamasaki
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, 3 1 1 Maidashi, Higashi ku, Fukuoka 812 8582, Japan
    Anticancer Res 31:2419-24. 2011
    ..These results suggest that γδ T-cells from cancer patients may be ideal candidates for adoptive immunotherapy...
  11. ncbi Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients
    Junji Wada
    Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    Anticancer Res 28:2401-8. 2008
    ..0034). These data suggest that the % Tregs among the PBMCs might be used as an effect prediction factor of immunotherapy for patients with advanced cancer...